Live Breaking News & Updates on Colin Rolph|Page 1

Stay updated with breaking news from Colin rolph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TearSolutions, Inc. Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Lacripep™

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , University Of Virginia , Marc Odrich , Gordon Laurie , Colin Rolph , University Of Virginia Licensing , Tearsolutions Inc , Drug Administration , Ventures Group , Dry Eye Disease , Chief Medical , Virginia Licensing , Chief Executive Officer , Chief Financial Officer , Coronavirus Pandemic , Globe Newswire ,

TearSolutions, Inc. Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Lacripep™

TearSolutions, Inc. Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Lacripep™ - read this article along with other careers information, tips and advice on BioSpace ....

United States , University Of Virginia , Marc Odrich , Gordon Laurie , Colin Rolph , University Of Virginia Licensing , Tearsolutions Inc , Drug Administration , Ventures Group , Dry Eye Disease , Chief Medical , Virginia Licensing , Chief Executive Officer , Chief Financial Officer , Nc Announces Outcome Of Typec Meeting With Fda And Next Steps In The Development Lacripep ,